Genome sequence of Eubacterium callanderi AM6, isolated from a Parkinson’s disease patient
Madhav Kumar, Lizbeth Sayavedra, Dave J. Baker, Yogesh S. Shouche, Arjan Narbad

TL;DR
This paper reports the genome sequence of Eubacterium callanderi AM6, a bacterium isolated from a Parkinson’s disease patient’s fecal sample.
Contribution
The novel contribution is the sequencing and characterization of the genome of Eubacterium callanderi AM6.
Findings
The genome of Eubacterium callanderi AM6 is 4,318,463 base pairs long.
The G + C content of the genome is 47.5%.
Abstract
Here, we report the genome sequence of Eubacterium callanderi AM6, isolated from a fecal sample obtained from a Parkinson’s disease patient. The bacterial genome was sequenced using Illumina technology on a NextSeq 500 platform. The assembled genome of Eubacterium callanderi comprises 4,318,463 base pairs with a G + C content of 47.5%.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsGenomics and Phylogenetic Studies · Bacteriophages and microbial interactions · RNA and protein synthesis mechanisms
ANNOUNCEMENT
Eubacterium callanderi is a non-motile, gram-positive, anaerobic gut bacterium that produces short-chain fatty acids, supporting gut health and potentially benefiting conditions like Inflammatory Bowel Disease (IBD) and metabolic syndromes (1–3). Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by motor dysfunction, dopamine loss, and potential gut-brain axis involvement. Studying Eubacterium callanderi from PD patients may reveal its role in gut-brain interactions, neuroinflammation, and potential as a biomarker or therapeutic target. There is limited research on Eubacterium callanderi isolated from patients with PD. Here, we report the genome sequence of Eubacterium callanderi strain AM6, isolated from the fecal sample of a PD patient.
A fecal sample from an 86-year-old female with idiopathic PD was collected in a collection pot, with anaerobic conditions maintained using an Anaerogen sachet until processing. The sample was aliquoted and stored at −80°C in the Norwich Research Park Biorepository (52.6125° N, 1.2417° E). The sample was enriched in Postgate C broth, streaked onto Postgate C agar, and incubated at 37°C for 72 hours under anaerobic conditions. Pure colonies were obtained after at least three subcultures for 24–30 hours. Genomic DNA was extracted from 1 mL of an overnight grown culture using the Maxwell RSC Cultured Cells DNA Kit (Promega, USA) according to the manufacturer’s instructions. DNA quantity was measured using a Qubit fluorometer, and the final library was analyzed with a Qubit 3.0 and Agilent TapeStation 4200. Illumina short-read sequencing was conducted using a modified protocol with a 20-fold dilution of the DNA Prep (Flex) reagent, and sequencing was performed on a NextSeq 500 platform with 150 bp paired-end reads.
Raw paired-end reads were processed using Fastp (version 0.23.4) for quality control and filtering (4). Genome assembly was performed with SPAdes (version 3.15.5) (5), and the assembled genome’s quality was assessed using QUAST (version 5.3.0) (6). The completeness of the genome was assessed using CheckM (7), yielding a value of 99.36%. The genome of E. callanderi AM6 comprises 4,318,463 bp with a G + C content of 47.5%, distributed across 35 contigs, and an N50 fragment size of 703,631 bp. The genome was sequenced using 2.165 million 150 bp paired-end reads, achieving a coverage depth of 75×. Annotation using the NCBI prokaryotic genome annotation pipeline (8) identified 4,145 genes, 4,060 protein-coding genes, 51 tRNAs, 4 rRNAs, and 1 ncRNA. Average nucleotide identity (ANI) analysis revealed that E. callanderi AM6 shares 98.4% ANI with type strain Eubacterium callanderi FD (accession FRBP00000000) (9), 94.08% ANI with Eubacterium limosum ATCC 8486 (accession CP019962), and 89.67% ANI with Eubacterium maltosivorans YI (accession CP029487). No plasmids were detected using PlasmidFinder (version 2.1.6) (10). Phage analysis using PHASTEST (11) identified two intact prophage regions: a 54.27-kb region (40.31% G + C content) similar to the Clostr_phiCD146 phage and a 35.88-kb region (42.17% G + C content) similar to the Clostr_PhiS63 phage. Whole genome-based taxonomic analysis was conducted using the Type (Strain) Genome Server (https://tygs.dsmz.de) (12), which validated the AM6 isolate as Eubacterium callanderi. Default parameters were used except where otherwise noted.
The reference list from the paper itself. Each links out to its DOI / PubMed record.
- 1Marsh AJ, Chandrashekhar K, Ng S, Roach J, Magness ST, Azcarate-Peril MA. 2020. Genome sequence of Eubacterium callanderi AMC 0717, isolated from the colonic mucosa of an 11-Year-old organ donor. Microbiol Resour Announc 9:10–128. doi:10.1128/MRA.00995-20PMC 766099833184159 · doi ↗ · pubmed ↗
- 2Ryu SW, Kim JS, Oh BS, Choi WJ, Yu SY, Bak JE, Park SH, Kang SW, Lee J, Jung WY, Lee JS, Lee JH. 2022. Gut microbiota Eubacterium callanderi exerts anti-colorectal cancer activity. Microbiol Spectr 10:e 0253122. doi:10.1128/spectrum.02531-2236448791 PMC 9769849 · doi ↗ · pubmed ↗
- 3Mukherjee A, Lordan C, Ross RP, Cotter PD. 2020. Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. Gut Microbes 12:1802866. doi:10.1080/19490976.2020.180286632835590 PMC 7524325 · doi ↗ · pubmed ↗
- 4Chen S, Zhou Y, Chen Y, Gu J. 2018. Fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34:i 884–i 890. doi:10.1093/bioinformatics/bty 56030423086 PMC 6129281 · doi ↗ · pubmed ↗
- 5Bankevich A, Nurk S, Antipov D, Gurevich AA, Dvorkin M, Kulikov AS, Lesin VM, Nikolenko SI, Pham S, Prjibelski AD, Pyshkin AV, Sirotkin AV, Vyahhi N, Tesler G, Alekseyev MA, Pevzner PA. 2012. SP Ades: a new genome assembly algorithm and its applications to single-cell sequencing. J Comput Biol 19:455–477. doi:10.1089/cmb.2012.002122506599 PMC 3342519 · doi ↗ · pubmed ↗
- 6Gurevich A, Saveliev V, Vyahhi N, Tesler G. 2013. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29:1072–1075. doi:10.1093/bioinformatics/btt 08623422339 PMC 3624806 · doi ↗ · pubmed ↗
- 7Parks DH, Imelfort M, Skennerton CT, Hugenholtz P, Tyson GW. 2015. Check M: assessing the quality of microbial genomes recovered from isolates, single cells, and metagenomes. Genome Res 25:1043–1055. doi:10.1101/gr.186072.11425977477 PMC 4484387 · doi ↗ · pubmed ↗
- 8Li W, O’Neill KR, Haft DH, Di Cuccio M, Chetvernin V, Badretdin A, Coulouris G, Chitsaz F, Derbyshire MK, Durkin AS, Gonzales NR, Gwadz M, Lanczycki CJ, Song JS, Thanki N, Wang J, Yamashita RA, Yang M, Zheng C, Marchler-Bauer A, Thibaud-Nissen F. 2021. Ref Seq: expanding the Prokaryotic Genome Annotation Pipeline reach with protein family model curation. Nucleic Acids Res 49:D 1020–D 1028. doi:10.1093/nar/gkaa 110533270901 PMC 7779008 · doi ↗ · pubmed ↗
